Showing results (311-320 of 339) with videos related to
Sort By:
Pageof 34
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 17, 2008
A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolatesG Blum, S Perkhofer, K Grif, et al.Immunology Letters|October 1, 1990
Immune activation markers to predict AIDS and survival in HIV-1 seropositivesD Fuchs, H Jäger, M Popescu, et al.European Journal of Biochemistry|February 1, 1994
Expression of properdin in human monocytesW Schwaeble, H P Huemer, J Möst, et al.FEBS Letters|April 19, 1993
Neopterin modulates toxicity mediated by reactive oxygen and chloride speciesG Weiss, D Fuchs, A Hausen, et al.Immunology Letters|August 1, 1989
HIV and HIV-infected cells differentially activate the human complement system independent of antibodyB M Sölder, T F Schulz, P Hengster, et al.Arzneimittel-Forschung|August 1, 1989
Effect of D-penicillamine on the expression and propagation of the human immunodeficiency virus by H9 T-lymphoblastoid cellsG Bitterlich, C Larcher, B Sölder, et al.Clinical Chemistry|December 1, 1988
Neopterin estimation compared with the ratio of T-cell subpopulations in persons infected with human immunodeficiency virus-1D Fuchs, M Banekovich, A Hausen, et al.British Journal of Haematology|May 1, 2001
Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignanciesC Lass-Flörl, J Aigner, E Gunsilius, et al.Cancer Detection and Prevention. Supplement : Official Publication of the International Society for Preventive Oncology, Inc|January 1, 1987
Activated T cells in addition to LAV/HTLV-III infection: a necessary precondition for development of AIDSD Fuchs, A Hausen, E Hoefler, et al.Immunobiology|October 26, 1999
Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitorsA Gruber, J Berlit, C Speth, et al.Pageof 34